Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ultragenyx Pharmaceutical Inc. Insider Profile
4 Followers
Ultragenyx Pharmaceutical Inc., Director at Arcturus Therapeutics, holds 1.40M shares in Arcturus Therapeutics (Ticker: ARCT). Most recently, Ultragenyx Pharmaceutical Inc. Sold $800,000 shares of Arcturus Therapeutics on Aug 12, 2021 for an estimated value of 43.63M.
Ultragenyx Pharmaceutical Inc. Arcturus Therapeutics (ARCT)Director
Arcturus Therapeutics (ARCT)
Director
Ranked #46,024 out of 98,501 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+5.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ultragenyx Pharmaceutical Inc.'s holdings
Insider Roles
Director
Roles that Ultragenyx Pharmaceutical Inc. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 12, 2021 - Aug 12, 2022
Return:+61.50%
The most profitable trade made by Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.'s Trading History
List of latest transactions for each holding click on a transaction to see Ultragenyx Pharmaceutical Inc.'s performance on stock
You May Also Like
Ultragenyx Pharmaceutical Inc. insider profile FAQ
What is the percentage of profitable transactions made by Ultragenyx Pharmaceutical Inc.?
The percentage of profitable transactions made by Ultragenyx Pharmaceutical Inc. is 50%.
What is the average return per transaction made by Ultragenyx Pharmaceutical Inc.?
The average return per transaction made by Ultragenyx Pharmaceutical Inc. is 5.50%.
What stocks does Ultragenyx Pharmaceutical Inc. hold?
Ultragenyx Pharmaceutical Inc. holds: ARCT stocks.
What was Ultragenyx Pharmaceutical Inc.’s latest transaction?
Ultragenyx Pharmaceutical Inc. latest transaction was an Informative Sell of $43.63M.
What was Ultragenyx Pharmaceutical Inc.'s most profitable transaction?
Ultragenyx Pharmaceutical Inc.’s most profitable transaction was an Informative Sell of ARCT stock on August 12, 2021. The return on the trade was 61.50%.
What is Ultragenyx Pharmaceutical Inc.'s role in Arcturus Therapeutics?
Ultragenyx Pharmaceutical Inc.'s role in Arcturus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.